[1]杜冠华.实验药理学.2版.北京:高等教育出版社,2021.
[2]黄家学,胡娟娟,刘艾林,等.高通量药物筛选活性数据的计算机处理.中国药学杂志,2000,35(3):145-147.
[3]张煜卓,戚涵姝,谷笑雨,等.分子对接在药物虚拟筛选中的应用进展.广州化学,2017,42(6):62-67.
[4]李晓,李达,周雪松,等.化合物ADMET性质预测平台的构建.生物信息学,2017,15(3):179-185.
[5]HART J.Vascular Myography To Examine Functional Responses Of Isolated Blood Vessels.Methods Mol Biol,2019,2007:205-217.
[6]SKRZYPIEC-SPRING M,GROTTHUS B,ADAM S A,et al.Isolated heart perfusion according to langendorff—still viable in the new millennium.J Pharmacol Toxicol Methods,2007,55(2):113-126.
[7]MITTAL R,WOO F W,CASTRO C S,et al.Organ-on-chip models:implications in drug discovery and clinical applications.J Cell Physiol,2019,234(6):8352-8380.
[8]ZHOU C,YOOL A J,BYARD R W.An Isolated perfused rat kidney model for the evaluation of the effect of glucose on renal tubular epithelial morphology.J Forensic Sci,2017,62(1):126-130.
[9]PASTOR C M.Isolated perfused rat livers to quantify the pharmacokinetics and concentrations of Gd-BOPTA.Contrast Media Mol Imaging,2018,2018:1-11.
[10]PHILIPPEOS C,HUGHES R D,DHAWAN A,et al.Introduction to cell culture.Methods Mol Biol,2012.806:1-13.
[11]牛其芳,李德龙,杨杨,等.人血管内皮细胞缺氧复氧损伤细胞模型的建立.中国口腔颌面外科杂志,2019,17(4):295-299.
[12]汤婷婷,刘华钢,梁燕,等.肿瘤多药耐药模型建立方法的应用进展.山东医药,2018,58(7):96-98.
[13]李伟,杨金才,黄牛.深度学习在药物设计与发现中的应用.药学学报,2019,54(5):761-767.
[14]何亚峰,陈浩.基于亲和探针的药物靶点鉴定技术研究进展.药学进展,2017,41(1):30-40.
[15]唐洪杰,任素梅,陆小兰.微波组合化学在新药研究中的应用.中国海洋大学学报,2004,34(3):461-467.
[16]刘晓蓉.微波组合化学在新药研究中的运用实践.化工管理,2020,1(2):171-172.
[17]谢峻,张静怡,汤宁,等.加兰他敏和石杉碱甲生物合成的研究进展.中草药,2020,51(3):812-820.
[18]沈培杰,祁峰,黄建忠.血清素生物合成方法的研究进展.药物生物技术,2020,27(1):68-72.
[19]范仕成,高悦,张慧贞,等.非靶向和靶向代谢组学在药物靶点发现中的应用.药学进展,2017,41(4):263-269.
[20]刘琦.人工智能与药物研发.第二军医大学学报,2018,39(8):869-872.
[21]陆涛.人工智能在医药领域的应用.药学进展,2019,44(1):1-3.
[22]PARVATHANENI V,KULKARNI N S,MUTH A,et al.Drug repurposing:a promising tool to accelerate the drug discovery process.Drug Discov Today.2019;24(10):2076-2085.
[23]ESCH E W,BAHINSKI A,HUH D.Organs-on-chips at the frontiers of drug discovery.Nat Rev Drug Discov,2015,14(4):248-260.
[24]LLOYD M D.High-throughput screening for the discovery of enzyme inhibitors.J Med Chem,2020,63(19):10742-10772.
[25]BERNARD P,DUFRESNE-FAVETTA C,FAVETTA P,et al.Application of drug repositioning strategy to TOFISOPAM.Curr Med Chem,2008,15(30):3196-3203.